0.2780
0.0000
(0.00%)
At close: April 17 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Jesse M. Jaynes Ph.D. | Chief Research Officer & Chairman | -- | -- | 1952 |
| Dr. Clayton Yates Ph.D. | Chief Scientific Officer & Director | -- | -- | 1977 |
| Mr. Chad Pawlak Sr. | CEO & Director | -- | -- | -- |
| Dr. Windy Dean-Colomb M.D., Ph.D. | Chief Clinical Officer | -- | -- | -- |
Genvor Incorporated
201 S. Elliott Road
Suite 538
Chapel Hill, NC 27514
United States
- Sector:
- Basic Materials
- Industry: Agricultural Inputs
Description
Genvor Incorporated develops plant-based defense technology designed to help farmers achieve global food security. The company was formerly known as Allure Worldwide, Inc. and changed its name to Genvor Incorporated in June 2022. Genvor Incorporated is headquartered in Chapel Hill, North Carolina.
Corporate Governance
Genvor Incorporated’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available